Paris, France

Carine Robert


 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Carine Robert: Innovator in Cancer Therapy

Introduction

Carine Robert is a prominent inventor based in Paris, France. She has made significant contributions to the field of cancer therapy, particularly in the development of methods to enhance the effectiveness of treatments for various cancers. With a total of 3 patents, her work focuses on innovative approaches to sensitizing cancer cells to therapies.

Latest Patents

Carine Robert's latest patents include groundbreaking methods for treating cancer cells. One of her notable inventions is a therapy regimen that utilizes low doses of DNA demethylating agents in conjunction with poly ADP ribose polymerase (PARP) inhibitors. This method aims to sensitize cancer cells treated with epigenetic therapy to PARP inhibitors across multiple cancer types. Another significant patent addresses ovarian cancer specifically, providing similar methods to enhance treatment efficacy.

Career Highlights

Throughout her career, Carine Robert has worked with esteemed institutions such as the University System of Maryland and The Johns Hopkins University. Her research has been pivotal in advancing cancer treatment methodologies, showcasing her dedication to improving patient outcomes.

Collaborations

Carine has collaborated with notable professionals in her field, including Feyruz Rassool and Stephen B Baylin. These partnerships have further enriched her research and contributed to the development of innovative cancer therapies.

Conclusion

Carine Robert stands out as a leading inventor in the realm of cancer therapy, with her patents reflecting a commitment to enhancing treatment options for patients. Her work continues to inspire advancements in medical research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…